Bromelain exerts anti-inflammatory effects in an ovalbumin-induced murine model of allergic airway disease

  • Jr E
  • Eric R. Secor Jr
  • William F. Carson IV
  • et al.
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objective—Bromelain, a clinically used pineapple extract and natural product, has reported anti- inflammatory and immunomodulatory activities. The purpose of this study was to determine the effect of bromelain treatment in an ovalbumin (OVA)-induced murine model of allergic airway disease (AAD). Methods—To establish AAD, mice were sensitized with intraperitoneal (i.p.) OVA/alum and challenged with daily OVA aerosols. Mice were treated i.p. with either saline, 2 or 6 mg/kg bromelain, twice daily for four consecutive days. Bronchoalveolar lavage leukocytes and cytokines, lung histology, airway hyperresponsiveness, and lymphocyte populations via flow cytometry were compared between groups. Results—Bromelain treatment of AAD mice resulted in reduced total BAL leukocytes, eosinophils, CD4+ and CD8+ T lymphocytes, CD4+/CD8+ T cell ratio, and IL-13. Conclusion—Bromelain attenuated development of AAD while altering CD4+ to CD8+ T lymphocyte populations. The reduction in AAD outcomes suggests that bromelain may have similar effects in the treatment of human asthma and hypersensitivity disorders

Cite

CITATION STYLE

APA

Jr, E. R. S., Eric R. Secor Jr, William F. Carson IV, Michelle M. Cloutier, Linda A. Guernsey, Craig M. Schramm, … Roger S. Thrall. (2008). Bromelain exerts anti-inflammatory effects in an ovalbumin-induced murine model of allergic airway disease. Cellular Immunology, 237(1), 68–75. https://doi.org/10.1016/j.cellimm.2005.10.002.Bromelain

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free